Zaria Cancer Consortium

To have a holistic approach involving diverse stakeholders towards improving cancer care outcomes and research in Africa.

[Advanced Prostate Cancer Consensus Conference @APCCC_Lugano]

A great Pleasure to Present our paper on Management of patients with Advanced #ProstateCancer : A Report from #APCCC24

LINK TO ARTICLE👇👇👇👇👇👇👇👇
https://t.co/QL8Kuyhxuj

The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) highlights significant advances in prostate cancer management while underscoring areas where high-quality evidence is still lacking.

The conference gathered expert opinions on controversial clinical issues, particularly in advanced prostate cancer, offering guidance in cases where guidelines are unclear or conflicting.

The report emphasizes personalized treatment approaches, considering patient-specific factors and evolving clinical data, and stresses the importance of ongoing clinical trials to fill knowledge gaps. It provides a practical framework for physicians and patients to engage in shared decision-making, especially in complex cases of high-risk localized and locally advanced prostate cancer.

Our Thanks to all authors:
@Silke_Gillessen
@fabioturco92
@Prof_IanD
@drjefstathiou
Karim Fizazi
@Prof_Nick_James
Neal Shore
Eric Small
Matthew Smith
@ChrisSweens1
@BertrandTOMBAL
@ZilliThomas
@neerajaiims
Emmanuel S. Antonarakis
Ana Aparicio
Andrew J. Armstrong
Diogo Assed Bastos
Gerhardt Attard
Karol Axcrona
Mouna Ayadi
Himisha Beltran
@bjartell
@PBlanchardMD
@BourlonMaite
@Albert0Briganti
Muhammad Bulbul
Consuelo Buttigliero
Orazio Caffo
@cdanicas
@Ecastromarcos
Heather H. Cheng
Kim N. Chi
Caroline S. Clarke
Noel Clarke
Johann S. de Bono
@mdesantis234
@nachoduranm
@EfstathiouEleni
Onyeanunam N. Ekeke
Tamer I.H. El Nahas
@drlouiseemmett
@stefanofanti4
Omolara A. Fatiregun
Felix Y. Feng
Peter C.C. Fong
@fontev1
@Nicola_Fossati
Daniel J. George
@marty_gleave
Gwenaelle Gravis
Susan Halabi
Daniel Heinrich
@ProfKHerrmann
@DrMHofman
Thomas A. Hope
Lisa G. Horvath
Maha H.A. Hussain
@BarbaraJereczek
Robert J. Jones
Anthony M. Joshua
@ravikanesvaran
Daniel Keizman
@FacsRaja
Gero Kramer
@LoebStacy
Brandon A. Mahal
Fernando C. Maluf 75 76,
@quimmateo
David Matheson 78,
Mika P. Matikainen 79,
Ray McDermott 80,
@DrRanaMcKay
Niven Mehra 82,
@amerseburger
@CaPsurvivorship ,
Michael J. Morris 85,
Hind Mrabti 86,
Deborah Mukherji
@declangmurphy
Vedang Murthy
Shingai B.A. Mutambirwa
@DrPaulNguyen
William K. Oh
@piet_ost
Joe M. O’Sullivan
Anwar R. Padhani
Chris Parker
Darren M.C. Poon
Colin C. Pritchard
Danny M Rabah
Dana Rathkopf
Robert E. Reiter
Raphaele Renard-Penna
Charles J. Ryan
Fred Saad
Juan Pablo Sade
Shahneen Sandhu
Oliver A. Sartor
Edward Schaeffer
Howard I. Scher
Nima Sharifi
Iwona A. Skoneczna
Howard R. Soule
@DrSpratticus
Sandy Srinivas
@cnsternberg
Hiroyoshi Suzuki
Mary-Ellen Taplin
Camilla Thellenberg-Karlsson
Derya Tilki
Levent N. Türkeri
Hiroji Uemura
@DrYukselUrun
Claire L. Vale
Neha Vapiwala
Jochen Walz
Kosj Yamoah
Dingwei Ye
Evan Y. Yu
Almudena Zapatero
@AOmlin

[Zaria Cancer Consortium @Zariacancerco11]

Improving access, education, and collaboration is crucial to address these challenges and better cancer overall survival rates from prostate cancer among Black men globally.

[Zaria Cancer Consortium @Zariacancerco11]

September prostate cancer awareness!
Black men face a higher incidence & mortality rate of prostate cancer due to in part disease-associated genetic variants, limited access to healthcare infrastructure, medicine, and technologies, and cultural barriers... @BIOVentures @CaPTC7

[Oluwaseyi Toye @nijitoye]

Together we can change the narrative.

[NICRAT @NicratGov]

𝗡𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗼𝗻 𝗖𝗮𝗻𝗰𝗲𝗿 𝗚𝗲𝗻𝗼𝗺𝗶𝗰𝘀, 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗖𝗮𝗿𝗲 𝗮𝗻𝗱 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗖𝗼𝗺𝗺𝘂𝗻𝗶𝘁𝘆 𝗛𝗲𝗮𝗹𝘁𝗵 𝗳𝗼𝗿 𝗕𝗹𝗮𝗰𝗸 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀: 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿, 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗲 & 𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗲
#nicratupdate #CancerGenomics #cancerprevention #CancerControl

[Fumiko Ladd Chino, MD, FASCO @fumikochino]

In a large cohort of pts with GI cancers screened for #financialtoxicity & health related social risks, over HALF were identified to have significant financial burdens & over ONE FOURTH had an unmet essential need.

Dr @KaitlynLapen presented yesterday afternoon #ASCO24

[Fumiko Ladd Chino, MD, FASCO @fumikochino]

Pts with #breastcancer report good provider communication skills overall...
But side effect profiles are not always well-explained.

This matters bc pts who reported poor communication were 64% less likely to take all recommended #bcsm care

#ASCO24: tweetorial coming later!

[Narjust Florez, MD, FASCO @NarjustFlorezMD]

When trial results make you tear up - because our young patients with EGFR unresectable stage III lung cancer.

#ASCO24

@RamalingamMD @EGFRResisters @DFEGFRcenter @OncogeneCancer @YoungLungCancer

[Noemi Reguart @NReguart]

Second practice changing trial of the day: ADRIATIC Durva consolidation vs plb after cCRT in LS-SCLC. Dual P. endpoints OS/PFS meet (3-y FUP): 24 mo OS gain (median 55.9 vs 33.4, HR 0.73) and 24% reduction in the risk of PFS/death (median 16.6 vs 9.2 mo, HR 0.76) #ASCO24 #LCSM

[Arndt Vogel @ArndtVogel]

🔥PLENARY Session #ASCO24🔥
Perioperative chemotherapy (FLOT) to neoadjuvant chemoradiation (CROSS) in patients with adenocarcinoma of the esophagus
🔎 ESOPEC phase III trial, 438 patients
👉R0 180 vs 171
👉pCR 17 vs 10%
👉mOS 66 vs 37 mo
👉3yr OS: 57.4 vs 50.7%
🧐FLOT improves OS compared to CROSS
@myESMO

[Mark Lewis, MD, FASCO @marklewismd]

Not every day that you get to celebrate a years-long survival advantage in the treatment of small cell lung cancer!!!

Mind-blowing to see the median overall survival for limited stage SCLC approach the oncologically conventional 5-year milestone #lcsm #ASCO24

[Zainab Shinkafi-Bagudu @DrZSB]

A wonderful evening with my @AORTIC_AFRICA family. Many issues raised around research in Africa. Comforting that organizations like @ASCO @NCIResearchCtr are actively funding and creating opportunities for researchers in Africa. #ASCO24

[Prof FTO 🇳🇬🇺🇸 @DrOdedina]

In less than 24 hours, @CaPTC7 , @iCCaRE4BlackMen and @ABeR_center will launch its first #NutritionRx in Badagry to address social determinants of health! The program is based on the @MayoCancerCare WellnessRx.

[Lorenzo de la Rica (he/him) @LdelaRica]

Congratulations to team SAMBAI, led by Melissa Davis @MeliD32 from @MSMEDU @ICSBCS! Long overdue challenge tackling cancer inequities that cause and influence disparate cancer outcomes in underserved populations of African descent.
Find out more: https://t.co/3vRE04pGkD

[Zaria Cancer Consortium @Zariacancerco11]

@DrOdedina @CaPTC7 @phd_yates Congratulations to the excellent team!

[Prof FTO 🇳🇬🇺🇸 @DrOdedina]

Congratulations. Great to see our @CaPTC7 PI @phd_yates representing!!!

[CaPTC @CaPTC7]

Our very own @PinkyProf turns 70 on March 8. Please use the information below to register to attend any, or both of the webinars advertised👇

[Ameenah Marafa @Marafa_Aminat]

The Coordinator, Kano Cancer Care Centre @AminuMagashiG conducting an orientation on Cancer Awareness to the Senior Special Reporter and Special Reporter to H.E. the governor of Kano State @Kyusufabba on Cancer Centre.

[Yehoda Martei MD, MSCE @ymartei]

Powerful image, illustrating inequity in clinical translation of global oncology research knowledge in Africa, presented by Dr. Gopal at #AORTIC2023

[Pierre Blanchard, MD @PBlanchardMD]

Why #radiotherapy with concomitant #chemotherapy is an excellent option for bladder preservation in #bladdercancer patients.

@robert_huddart gives as always an excellent overview at #ESMO23.

Patient preferences and priorities are central here.